Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Yes, darolutamide plus ADT significantly delays pain progression in metastatic hormone-sensitive prostate cancer, based on the ARANOTE phase 3 trial.
Yes, cohort studies are the most common study type in pediatric ARI research, providing key data on pathogen profiles, co-infections, seasonal patterns, and clinical outcomes…
EBUS-guided transbronchial mediastinal cryobiopsy (EBUS-TBMC) has the highest diagnostic yield for lymphoma in the mediastinum, outperforming standard EBUS-TBNA.
No, olezarsen did not significantly reduce noncalcified plaque volume over 12 months in adults with moderate hypertriglyceridemia, despite lowering triglycerides by ~60%.
No, Frexalimab, Brivekimig, and Rilzabrutinib are not being tested together. A current Phase 2 study tests these drugs individually against a placebo to see which one reduces…
Yes, cerebral infarction is common in children with tuberculous meningitis, especially in severe disease, with rates up to 50% in some studies.
Yes, arterial occlusion is a key mechanism linking cerebral infarction to disease severity in tuberculous meningitis, as shown by a secondary analysis of the ACT-TBM trial.
Yes, obinutuzumab has shown promise in case reports and small studies for FSGS patients who did not respond to rituximab, but larger trials are needed.
Chronic air pollution in Puerto Rico increases risks of cancer, respiratory, and cardiovascular diseases, especially in children and older adults, through microbiome disruption…
People with chronic lung disease face higher risks of severe COVID-19 if they also have conditions like diabetes, heart disease, or smoking history.
Dipstick urinalysis has high specificity but low sensitivity for detecting UTIs in infants under 12 months, meaning it can rule in infection but often misses it.
A dipstick test is fairly accurate for UTI in febrile infants under 12 months, with high specificity (91-99%) but moderate sensitivity (60-90%), meaning it rules in infection…
Current blood tests can show patterns that separate patients who develop delayed cerebral ischemia from those who do not, but no single standard test exists yet for predicting…
Yes, Rytelo (imetelstat) is FDA-approved for adults with low- to intermediate-1 risk MDS and transfusion-dependent anemia who need ≥4 RBC units over 8 weeks and have not…
Early blood tests for metabolites like calprotectin, melatonin, and specific gut-derived compounds can help predict delayed cerebral ischemia (DCI) before symptoms appear, though…
Yes, Revlimid (lenalidomide) is FDA-approved for transfusion-dependent anemia in low- or intermediate-1-risk MDS with a deletion 5q abnormality.
About 30.5% of children with VUR on antibiotic prophylaxis experience a breakthrough UTI, with higher risk in infants, high-grade reflux, and those with kidney scarring.
Yes, newer drugs like luspatercept, imetelstat, and lenalidomide are approved for anemia in lower-risk MDS, with more in development.
Co-infection, especially with Mycoplasma pneumoniae, is a significant risk factor for severe CAP in children with HMPV, with studies showing higher rates of co-infection in…
In a recent study of hospitalized children with HMPV, 28.0% had severe community-acquired pneumonia (CAP).
Yes, Revlimid (lenalidomide) is FDA-approved for transfusion-dependent anemia in low- or intermediate-1-risk MDS with a deletion 5q abnormality.
Yes, machine learning models, particularly GBDT and XGBoost, have outperformed APACHE-II in predicting mortality for severe community-acquired pneumonia with respiratory failure.
Yes, the FDA approved Rytelo (imetelstat) in June 2024 for adults with low- to intermediate-1 risk MDS who have transfusion-dependent anemia and have not responded to or are…
Yes, children with severe community-acquired pneumonia are more likely to have Mycoplasma pneumoniae, with studies showing higher detection rates in severe cases.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.